419 related articles for article (PubMed ID: 10880973)
1. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
[TBL] [Abstract][Full Text] [Related]
2. Immunological evidence for hypochlorite-modified proteins in human kidney.
Malle E; Woenckhaus C; Waeg G; Esterbauer H; Gröne EF; Gröne HJ
Am J Pathol; 1997 Feb; 150(2):603-15. PubMed ID: 9033274
[TBL] [Abstract][Full Text] [Related]
3. Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Hazell LJ; Arnold L; Flowers D; Waeg G; Malle E; Stocker R
J Clin Invest; 1996 Mar; 97(6):1535-44. PubMed ID: 8617887
[TBL] [Abstract][Full Text] [Related]
4. Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol.
Malle E; Wäg G; Thiery J; Sattler W; Gröne HJ
Biochem Biophys Res Commun; 2001 Dec; 289(4):894-900. PubMed ID: 11735131
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis.
Gröne HJ; Gröne EF; Malle E
Lab Invest; 2002 Jan; 82(1):5-14. PubMed ID: 11796821
[TBL] [Abstract][Full Text] [Related]
6. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies.
Malle E; Hazell L; Stocker R; Sattler W; Esterbauer H; Waeg G
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):982-9. PubMed ID: 7541296
[TBL] [Abstract][Full Text] [Related]
7. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
Hazen SL; Heinecke JW
J Clin Invest; 1997 May; 99(9):2075-81. PubMed ID: 9151778
[TBL] [Abstract][Full Text] [Related]
8. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
Jerlich A; Fabjan JS; Tschabuschnig S; Smirnova AV; Horakova L; Hayn M; Auer H; Guttenberger H; Leis HJ; Tatzber F; Waeg G; Schaur RJ
Free Radic Biol Med; 1998 May; 24(7-8):1139-48. PubMed ID: 9626568
[TBL] [Abstract][Full Text] [Related]
9. Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis.
Hazell LJ; Baernthaler G; Stocker R
Free Radic Biol Med; 2001 Nov; 31(10):1254-62. PubMed ID: 11705704
[TBL] [Abstract][Full Text] [Related]
10. Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL.
Exner M; Hermann M; Hofbauer R; Hartmann B; Kapiotis S; Gmeiner B
Free Radic Biol Med; 2004 Jul; 37(2):146-55. PubMed ID: 15203186
[TBL] [Abstract][Full Text] [Related]
11. Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of endothelial nitric-oxide synthase.
Nuszkowski A; Gräbner R; Marsche G; Unbehaun A; Malle E; Heller R
J Biol Chem; 2001 Apr; 276(17):14212-21. PubMed ID: 11278358
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase-dependent generation of hypochlorite-modified proteins in human placental tissues during normal pregnancy.
Hammer A; Desoye G; Dohr G; Sattler W; Malle E
Lab Invest; 2001 Apr; 81(4):543-54. PubMed ID: 11304574
[TBL] [Abstract][Full Text] [Related]
13. Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases.
Zhang C; Yang J; Jacobs JD; Jennings LK
Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2563-72. PubMed ID: 14613914
[TBL] [Abstract][Full Text] [Related]
14. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols.
Hazen SL; Hsu FF; Duffin K; Heinecke JW
J Biol Chem; 1996 Sep; 271(38):23080-8. PubMed ID: 8798498
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction.
Abdo AI; Rayner BS; van Reyk DM; Hawkins CL
Redox Biol; 2017 Oct; 13():623-632. PubMed ID: 28818791
[TBL] [Abstract][Full Text] [Related]
16. Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
Ismael FO; Proudfoot JM; Brown BE; van Reyk DM; Croft KD; Davies MJ; Hawkins CL
Arch Biochem Biophys; 2015 May; 573():40-51. PubMed ID: 25795019
[TBL] [Abstract][Full Text] [Related]
17. Hypochlorite-modified low-density lipoprotein induces the apoptotic machinery in Jurkat T-cell lines.
Resch U; Semlitsch M; Hammer A; Susani-Etzerodt H; Walczak H; Sattler W; Malle E
Biochem Biophys Res Commun; 2011 Jul; 410(4):895-900. PubMed ID: 21708126
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.
Daugherty A; Dunn JL; Rateri DL; Heinecke JW
J Clin Invest; 1994 Jul; 94(1):437-44. PubMed ID: 8040285
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions.
Moguilevsky N; Zouaoui Boudjeltia K; Babar S; Delrée P; Legssyer I; Carpentier Y; Vanhaeverbeek M; Ducobu J
Biochem Biophys Res Commun; 2004 Oct; 323(4):1223-8. PubMed ID: 15451427
[TBL] [Abstract][Full Text] [Related]
20. Chlorination and oxidation of the extracellular matrix protein laminin and basement membrane extracts by hypochlorous acid and myeloperoxidase.
Nybo T; Dieterich S; Gamon LF; Chuang CY; Hammer A; Hoefler G; Malle E; Rogowska-Wrzesinska A; Davies MJ
Redox Biol; 2019 Jan; 20():496-513. PubMed ID: 30476874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
